Results 151 to 160 of about 3,018,546 (285)
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Amharic version of the work-life balance scale: validation and psychometric properties. [PDF]
Teshome W +4 more
europepmc +1 more source
Tumor mutational burden as a determinant of metastatic dissemination patterns
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
A short mental health literacy scale: validation and application in Brazil. [PDF]
Buta BO, Couto VVD, Froner MB, Tabak BM.
europepmc +1 more source
Adherence to treatment and harmful effects of medication shortages in the context of severe crises: scale validation and correlates. [PDF]
Bou Malhab S +6 more
europepmc +1 more source
Validation of mathematical manoeuvring models by full scale measurements [PDF]
Delefortrie, Guillaume +4 more
core
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Italian Technostress Creators Scale: Validation of an Assessment Tool. [PDF]
Rossi MF +5 more
europepmc +1 more source
Better characterizing sleep beliefs for personalized sleep health promotion: the French sleep beliefs scale validation study. [PDF]
Coelho J +13 more
europepmc +1 more source

